About TICE BCG
            
            Class: | Immunotherapy, Bacillus Calmette-Guérin (BCG)  
Use: | Treatment of superficial bladder cancer (transitional cell carcinoma) and as a prophylactic treatment to reduce recurrence of bladder tumors  
Adult dose: | 5 x 10^8 CFU (colony-forming units) administered intravesically once a week for 6 weeks, followed by maintenance therapy as indicated  
Pediatric dose: | Safety and efficacy have not been established in pediatric patients; use is not recommended  
Side effects: | Common side eff
         
        
            
                
                
                    
                        Drug Class
                    
                    Immunotherapy, Bacillus Calmette-Guérin (BCG)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of superficial bladder cancer (transitional cell carcinoma) and as a prophylactic treatment to reduce recurrence of bladder tumors
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Medac GmbH, GERMANY
                    
                    
                    Package Size
                    1 Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 2098.75
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        5 x 10^8 CFU (colony-forming units) administered intravesically once a week for 6 weeks, followed by maintenance therapy as indicated
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy have not been established in pediatric patients; use is not recommended
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include dysuria, hematuria, bladder irritation, flu-like symptoms, and fatigue
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Active urinary tract infection, systemic BCG infection, severe hypersensitivity to BCG or any component of the formulation, and immunocompromised states
         
        
        
            
                Important Warnings
            
            Risk of severe systemic infection; monitor for signs of infection; may cause granulomatous reactions; use caution in patients with a history of tuberculosis or other chronic lung diseases
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.